Literature DB >> 1587611

Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages.

J N Verma1, M Rao, S Amselem, U Krzych, C R Alving, S J Green, N M Wassef.   

Abstract

Liposomes containing lipid A induced potent humoral immune responses in mice against an encapsulated malaria antigen (R32NS1) containing NANP epitopes. The immune response was not enhanced by lipid A alone or by empty liposomes containing lipid A. Experiments to investigate the adjuvant mechanisms of liposomes and lipid A revealed that liposome-encapsulated R32NS1 was actively presented by bone marrow-derived macrophages to NANP-specific cloned T cells. The degree of presentation was related to the amount of liposomal antigen added per macrophage in the culture medium. At high cell densities, poor presentation occurred when liposomes lacked lipid A but excellent presentation occurred when the liposomes contained lipid A. Liposomes containing lipid A and encapsulated antigen also activated gamma interferon-treated macrophages to produce nitric oxide. Macrophage activation and antigen presentation occurred with liposomes that could not be detected by the Limulus amebocyte lysis assay. Intraperitoneal injection of liposomal lipid A caused a marked increase in the recruitment of immature (peroxidase-positive) macrophages to the peritoneum. On the basis of these experiments, we propose that the mechanism of the adjuvant action of liposomal lipid A is partly due to increased antigen presentation by macrophages and partly due to recruitment of an increased number of macrophages serving as antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587611      PMCID: PMC257178          DOI: 10.1128/iai.60.6.2438-2444.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells.

Authors:  C V Harding; D S Collins; J W Slot; H J Geuze; E R Unanue
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumors.

Authors:  P Dal Monte; F C Szoka
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

3.  Complement-dependent phagocytosis of liposomes by macrophages.

Authors:  N M Wassef; C R Alving
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.

Authors:  M Belosevic; C E Davis; M S Meltzer; C A Nacy
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

5.  Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine.

Authors:  L S Rickman; D M Gordon; R Wistar; U Krzych; M Gross; M R Hollingdale; J E Egan; J D Chulay; S L Hoffman
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

6.  Incorporation of LPS in liposomes diminishes its ability to induce tumoricidal activity and tumor necrosis factor secretion in murine macrophages.

Authors:  J Dijkstra; J W Larrick; J L Ryan; F C Szoka
Journal:  J Leukoc Biol       Date:  1988-05       Impact factor: 4.962

7.  Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen.

Authors:  R L Richards; M D Hayre; W T Hockmeyer; C R Alving
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

8.  Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.

Authors:  T Daemen; A Veninga; J Dijkstra; G Scherphof
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

9.  Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes.

Authors:  J Dijkstra; J W Mellors; J L Ryan; F C Szoka
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

10.  Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A.

Authors:  R L Richards; G M Swartz; C Schultz; M D Hayre; G S Ward; W R Ballou; J D Chulay; W T Hockmeyer; S L Berman; C R Alving
Journal:  Vaccine       Date:  1989-12       Impact factor: 3.641

View more
  18 in total

1.  Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.

Authors:  K A Jolley; L Appleby; J C Wright; M Christodoulides; J E Heckels
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 2.  Adjuvants for human vaccines.

Authors:  Carl R Alving; Kristina K Peachman; Mangala Rao; Steven G Reed
Journal:  Curr Opin Immunol       Date:  2012-04-19       Impact factor: 7.486

3.  Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.

Authors:  N K Childers; K L Miller; G Tong; J C Llarena; T Greenway; J T Ulrich; S M Michalek
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen.

Authors:  R L Richards; M Rao; N M Wassef; G M Glenn; S W Rothwell; C R Alving
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate.

Authors:  Miao-Chiu Hung; Omar Salim; Jeannette N Williams; John E Heckels; Myron Christodoulides
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

6.  Intracellular processing of liposome-encapsulated antigens by macrophages depends upon the antigen.

Authors:  M Rao; N M Wassef; C R Alving; U Krzych
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

7.  Antitumor reactivity induced by liposomal MTP-PE in a liver metastasis model of colon cancer in the rat.

Authors:  K Thomas; A M Nijenhuis; B H Dontje; T Daemen; G L Scherphof
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

8.  A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors.

Authors:  Upkar Bhardwaj; Fotios Papadimitrakopoulos; Diane J Burgess
Journal:  J Diabetes Sci Technol       Date:  2008-11

9.  Enhancing nicotine vaccine immunogenicity with liposomes.

Authors:  Jonathan W Lockner; Sam On Ho; Karen C McCague; Su Ming Chiang; Thai Q Do; Gary Fujii; Kim D Janda
Journal:  Bioorg Med Chem Lett       Date:  2012-12-27       Impact factor: 2.823

10.  Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins.

Authors:  M V Norgard; B S Riley; J A Richardson; J D Radolf
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.